Investors & Media

Stock Information

Genexine is a clinical stage biotechnology company focused on the development and commercialization of innovative therapeutic vaccines and next generation Fc fusion protein drugs. Our goal is to bring to patients medicines that will transform patients’ lives.

Stock Quote
UPDATE : 2017-05-26 18:07:20
KOSDAQ: GENEXINE (095700)
EXCHANGE PRICE CHANGE (%) VOLUME
Genexine Inc (KRW) 42,700 ▲1,400 (+3.39 %) 153,494